Skip to content
healthcare.dev

Simlandi

NDC 51759-274, adalimumab-ryvk, kit, from Teva Pharmaceuticals USA, Inc..

Product NDC
51759-274
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
KIT
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761299
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51759-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
51759-274-17517590274171 KIT in 1 CARTON (51759-274-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (51759-384-21) * .4 mL in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12f609c9-2088-bb05-e063-6394a90a9ecc

Use it

Look up 51759-274 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51759-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51759-274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.